lung-cancer

Documents about lung-cancer

• Present and Future of Emerging Catalysts in Gas Sensors for Breath Analysis#348035KOASAS: KAIST Open Access Self-Archiving System
• Integrating Structured Expert Elicitation with External Evidence to Inform Earlier Reimbursement Decisions: A Norwegian Case Study of Selpercatinib for Non-Small Cell Lung Cancer.#382576NCBI PubMed Central
• A Safety and Tolerability Study of NC318 in Combination With Chemotherapy for Subjects With Advanced or Metastatic NSCLC#426792ClinicalTrials.gov
• Multimodal profiling for prediction of primary resistance to anti-PD-(L)1 therapy in advanced non-small-cell lung cancer: the prospective PIONeeR biomarkers study#429584bioRxiv / medRxiv
• A Single-center, Phase II Clinical Trial Evaluating the Efficacy of Sacituzumab Tirumotecan in Combination With Tagitanlimab as Neoadjuvant Therapy for PD-L1-positive, Resectable Stage II to IIIB Non-small Cell Lung Cancer (NSCLC)#127587ClinicalTrials.gov
• Phase 1 Study of Intradermal LV305 in Patients With Locally Advanced, Relapsed or Metastatic Cancer Expressing NY-ESO-1#287531ClinicalTrials.gov
• Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer#148580ClinicalTrials.gov
• Experiences of psychosomatic symptoms and self-management strategies among patients with advanced lung cancer undergoing chemotherapy: a qualitative study based on symptom management theory.#4260NCBI PubMed Central
• Pragmatic Randomized Control Trial of Telehealth vs Standard Care in Follow-up of Patients With Chronic Conditions#148686ClinicalTrials.gov
• Transcription Factor Subtype Governs Response and Resistance to DLL3-Directed T-Cell Engagement in Small Cell Lung Cancer#164904Unpaywall
• Data Management and Sharing Plan for: SBIR: A multicenter study in bronchoscopy combining Stimulated Raman Histology with Artificial intelligence for rapid lung cancer detection - The ON-SITE study#265864UNC Dataverse Dataverse OAI Archive
• AI-based radiomic features predict outcomes and the added benefit of chemoimmunotherapy over chemotherapy in extensive stage small cell lung cancer: A multi-institutional study.#275656NCBI PubMed Central
• Immunotherapy and Carbon Ion Radiotherapy In Solid Cancers With Stable Disease#321701ClinicalTrials.gov
• Lung cancer pathway inequalities for adults with severe mental health conditions: A mixed-methods analysis of barriers to screening and care pathways in South East London#349770bioRxiv / medRxiv
• Socioeconomic Determinants of Guideline-Concordant Therapy for Early-Stage Non-Small Cell Lung Cancer: A Population-Based Analysis from Appalachian and Non-Appalachian Ohio, 2004-2015#390893bioRxiv / medRxiv
• The ATG14–SIRT1 Axis Modulates NF-Κb Pathway Activation and Inflammatory Responses in Acute Lung Injury#391585Figshare
• Semantic CT features and differentiation model: new primary lung cancer versus metastasis after previous malignancy#437842Springer Nature OA
• Functional restoration of conformational (R175H) and contact (R273H) mutant p53 by Bacillus-derived Hydroxymycotrienin A in non-small cell lung cancer: a computational approach.#439109NCBI PubMed Central
• Image 3_Case Report: Short-term response to mesenchymal epithelial transition inhibitor/epidermal growth factor receptor tyrosine kinase inhibitor combination in EGFR-mutated non-small cell lung cancer with acquired MET overexpression after progression and discussion on comprehensive management.tif#367121Figshare
• Image 4_Case Report: Short-term response to mesenchymal epithelial transition inhibitor/epidermal growth factor receptor tyrosine kinase inhibitor combination in EGFR-mutated non-small cell lung cancer with acquired MET overexpression after progression and discussion on comprehensive management.tif#367122Figshare
• Image 1_Case Report: Short-term response to mesenchymal epithelial transition inhibitor/epidermal growth factor receptor tyrosine kinase inhibitor combination in EGFR-mutated non-small cell lung cancer with acquired MET overexpression after progression and discussion on comprehensive management.tif#367123Figshare
• Image 2_Case Report: Short-term response to mesenchymal epithelial transition inhibitor/epidermal growth factor receptor tyrosine kinase inhibitor combination in EGFR-mutated non-small cell lung cancer with acquired MET overexpression after progression and discussion on comprehensive management.tif#367124Figshare
• sc-rDSeq: a robust and cost-effective full-length total RNA sequencing method for single cells reveals multilayered heterogeneity in drug-resistant lung cancer cells.#13523NCBI PubMed Central
• Chinese Herbal Medicine Is Associated With Improved Survival in Patients With Advanced Lung Cancer Receiving Standard Treatment: A Nationwide Population-Based Propensity Score Matching Study.#15131NCBI PubMed Central
• Augmenting Large Language Model With Prompt Engineering and Supervised Fine-Tuning in Non-Small Cell Lung Cancer Tumor-Node-Metastasis Staging: Framework Development and Validation.#18486NCBI PubMed Central
• Comparative short-term outcomes of robotic-assisted vs video-assisted thoracic surgery in lung cancer: a multicenter retrospective study from EPITHOR with a quality audit#26258HAL (France)
• Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors#136314ClinicalTrials.gov
• Mindful self-compassion to reduce stigma among individuals diagnosed with lung cancer (MSC-LC): a pilot study protocol for a parallel-group, randomized controlled trial.#146109NCBI PubMed Central
• Marker-based CRISPR screens identify POU2F1 as a regulator of DLL3 and neuroendocrine identity in small cell lung cancer#169064Unpaywall
• TCF1+CD4+ T cells and microglia co-orchestrate tertiary lymphoid structures to enhance prognosis and immunotherapy in non-small cell lung cancer with brain metastases.#170676NCBI PubMed Central
• Study of Atezolizumab in Advanced Non-oncogene-addicted NSCLC With PD-L1 ≥50%, Including Longitudinal c-FLIP Assessment in Monocytic MDSCs.#172291ClinicalTrials.gov
• Effects of a computer-based applications intervention on anxiety, depression and quality of life among lung cancer patients: a systematic review and meta‑analysis#201272Universiti Putra Malaysia Institutional Repository
• Detecting actionable mutations from matched plasma-based versus tissue next-generation sequencing in advanced non-small cell lung cancer: a retrospective single centre analysis on site#208776HAL (France)
• A contamination-adjusted tissue thrombopoietic framework identifies a clinically relevant CAF-myeloid niche in non-small cell lung cancer: a paired transcriptomic and survival study.#242256NCBI PubMed Central
• The rechallenge benefit score: A clinical decision tool for patients progressing after immunotherapy#280409HAL (France)
• Prognostic associations between patient-reported outcomes and overall survival among patients with advanced squamous non-small cell lung cancer: results from the RATIONALE-307 trial.#298919NCBI PubMed Central
• In- and ex-vivo molecular imaging of apoptosis to assess sensitivity of non-small cell lung cancer to EGFR inhibitors using probe-based confocal laser endomicroscopy#312101HAL (France)
• A Phase 1 Clinical Study of AZD4635 in Patients With Advanced Solid Malignancies#343826ClinicalTrials.gov
• Supplemental Material for: Rapid Regression of Choroidal Metastasis Under First-Line Osimertinib Therapy in EGFR-Mutated Non–Small Cell Lung Cancer: A Case Report#436092Figshare
• SYS6010 Combined With Enlonstobart Versus Immunotherapy+ Platinum-based Chemotherapy for Patients With PD-L1-Positive Locally Advanced or Metastatic NSCLC（SYNSTAR 04）#444863ClinicalTrials.gov
• Setting Up an Ultra-Fast Next-Generation Sequencing Approach as Reflex Testing at Diagnosis of Non-Squamous Non-Small Cell Lung Cancer; Experience of a Single Center (LPCE, Nice, France)#226862HAL (France)
• A data-driven cartography of NSCLC vaccine research: Quantifying the paradigm shift toward immuno-oncology combination therapies#4675Europe PMC
• Suppression of PP2A-B56α drives EMT in EGFR mutant non-small cell lung cancer#176518Springer Nature OA
• Corrigendum to “A reproducibility study on invasion in small pulmonary adenocarcinoma according to the WHO and a modified classification, supported by biomarkers” [Lung Cancer 199 (2025) 108060]#205746HAL (France)
• Medical Record Study on Adverse Events Requiring a Higher Level of Care in Flemish Hospitals#366544ClinicalTrials.gov
• TNM-Accountable Whole-Body 3-Dimensional Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Report Drafting in Lung Cancer Cohorts via Structured Impressions and Organ-wise Exemplar Synthesis.#392854NCBI PubMed Central
• Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas#195398ClinicalTrials.gov
• Daily Practice Assessment of KRAS Status in NSCLC Patients: A New Challenge for the Thoracic Pathologist Is Right around the Corner#215405HAL (France)
• The complete treatment and management of brain metastases in a patient with limited-stage small cell lung cancer under molecular residual disease (MRD) monitoring: a case report.#280986NCBI PubMed Central
• The strategic roles of four enzymes in the interconnection between metabolism and oncogene activation in non-small cell lung cancer: Therapeutic implications#350797HAL (France)